Clinical Trial

Study to Evaluate a New Cartilage Regeneration Platform for Knee Cartilage Repair

Study acronym: TCW
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if a new treatment works to help regrow knee cartilage in people with knee cartilage damage. The main questions it aims to answer are: Does the treatment help the knee work better and lower pain more than the standard surgery? Is the treatment safe and does it help grow stronger new cartilage? Researchers will compare participants who get the standard surgery (microfracture) to participants who get both the standard surgery and the new treatment. This is to see if the new treatment leads to a better and faster recovery. Participants will: Have a surgery to treat their knee cartilage damage. Visit the clinic for check-ups to see how well their knee moves. Take imaging tests, like an MRI, so researchers can look at the new cartilage.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-07-29
Trial Details
NCT Number NCT07639424
Lead Sponsor ROKIT Healthcare
Conditions Cartilage Defects of the Knee
Enrollment 104 participants
Start Date 2025-12-29
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-28